Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q307088> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- Q307088 subject Q7211373.
- Q307088 subject Q8353060.
- Q307088 subject Q8497488.
- Q307088 abstract "Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.While abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 96 to 120 hours after discontinuation of the drug.(Tanguay, J.F., Eur Heart J 1999; 1 (suppl E): E27-E35Abciximab is made from the Fab fragments of an immunoglobulin that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.".
- Q307088 atcPrefix "B01".
- Q307088 atcSuffix "AC13".
- Q307088 casNumber "143653-53-6".
- Q307088 drugbank "DB00054".
- Q307088 fdaUniiCode "X85G7936GV".
- Q307088 wikiPageExternalLink www.reopro.com.
- Q307088 wikiPageWikiLink Q101026.
- Q307088 wikiPageWikiLink Q1588755.
- Q307088 wikiPageWikiLink Q166019.
- Q307088 wikiPageWikiLink Q18028014.
- Q307088 wikiPageWikiLink Q2335787.
- Q307088 wikiPageWikiLink Q30.
- Q307088 wikiPageWikiLink Q458127.
- Q307088 wikiPageWikiLink Q47270.
- Q307088 wikiPageWikiLink Q497232.
- Q307088 wikiPageWikiLink Q539795.
- Q307088 wikiPageWikiLink Q585285.
- Q307088 wikiPageWikiLink Q632240.
- Q307088 wikiPageWikiLink Q640448.
- Q307088 wikiPageWikiLink Q7211373.
- Q307088 wikiPageWikiLink Q721432.
- Q307088 wikiPageWikiLink Q79460.
- Q307088 wikiPageWikiLink Q8353060.
- Q307088 wikiPageWikiLink Q8497488.
- Q307088 wikiPageWikiLink Q909628.
- Q307088 atcPrefix "B01".
- Q307088 atcSuffix "AC13".
- Q307088 casNumber "143653".
- Q307088 drugbank "DB00054".
- Q307088 unii "X85G7936GV".
- Q307088 type ChemicalSubstance.
- Q307088 type Drug.
- Q307088 type ChemicalObject.
- Q307088 type Thing.
- Q307088 type Q8386.
- Q307088 comment "Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery.".
- Q307088 label "Abciximab".
- Q307088 homepage www.reopro.com.